AI SummaryBeta
Building summary
AI-generated from Traded deal data. May contain errors.
About
Cerenome Inc. is a CNS oncology company that focuses on advancing an integrated platform combining precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The company was formerly known as Plus Therapeutics and rebranded in August 2026, now trading under the Nasdaq ticker symbol CNSY.
Focus
Life Sciences
Lease
Markets
Headquarters
6420 Levit Green Blvd, Suite 210
FAQs
Cerenome Inc. has financed 1 deal.
Cerenome Inc.'s most recent deal was on August 20, 2026.
Member since: August 2026
Deals
Transaction Type
Asset Type
State
Sort By
LEASED
Cerenome Inc. Expands Lease To 36,500 Square Feet At Hines' Levit Green In Houston
6420 Levit Green Boulevard, Houston, TX
TXCRE
mh
Aug 20, 2026